Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Profile for Applicant: Mcneil Cons

« Back to Dashboard

Summary for Applicant: Mcneil Cons

Patents:8
Tradenames:22
Ingredients:12
NDAs:29
Drug Master File Entries: (click here to view)9
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mcneil Consumer
MOTRIN
ibuprofen
TABLET;ORAL017463May 22, 1985DISCNNo<disabled><disabled>
Mcneil Cons
IMODIUM
loperamide hydrochloride
CAPSULE;ORAL017694Approved Prior to Jan 1, 1982RXYes<disabled><disabled>
Mcneil Cons
CHILDREN'S ZYRTEC ALLERGY
cetirizine hydrochloride
TABLET, CHEWABLE;ORAL021621Nov 16, 2007DISCNNo6,455,533<disabled>Y<disabled>
Mcneil Cons
PEPCID AC
famotidine
TABLET;ORAL020325Apr 28, 1995OTCNo5,854,267*PED<disabled>Y<disabled>
Mcneil Cons
SUDAFED 24 HOUR
pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL020021Dec 15, 1992OTCYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
This search can help find similar names.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc